Singapore markets closed

Straits Times Index
3,336.59
+13.21(+0.40%)
Nikkei
38,487.90
+433.77(+1.14%)
Hang Seng
18,079.61
-150.58(-0.83%)
FTSE 100
8,275.38
+44.33(+0.54%)
Bitcoin USD
67,667.89
-470.19(-0.69%)
CMC Crypto 200
1,422.89
-5.68(-0.40%)

ALKS Nov 2024 29.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.9700

0.0000

(0.00%)

At close: 10:27AM EDT

Zacks
Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PR Newswire
Alkermes to Participate in Two Upcoming Investor Conferences
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.
PR Newswire
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
Alkermes plc (Nasdaq: ALKS) today announced plans to present three posters related to ALKS 2680 at SLEEP 2024, the 38th annual meeting of the Associated Professional Sleep Societies (APSS), taking place June 1-5, 2024 in Houston. ALKS 2680 is the company's novel, investigational, oral orexin 2 receptor (OX2R) agonist in development as a once-daily treatment for narcolepsy.